AtriCure, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
AtriCure, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • AtriCure, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $172M, a 4.15% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $172M +$6.85M +4.15% Dec 31, 2023 10-K 2024-02-16
Q4 2022 $165M +$11.1M +7.23% Dec 31, 2022 10-K 2024-02-16
Q4 2021 $154M +$36.8M +31.4% Dec 31, 2021 10-K 2023-02-22
Q4 2020 $117M +$15.8M +15.7% Dec 31, 2020 10-K 2022-02-17
Q4 2019 $101M +$31.3M +44.9% Dec 31, 2019 10-K 2021-02-26
Q4 2018 $69.8M +$2.88M +4.29% Dec 31, 2018 10-K 2020-02-24
Q4 2017 $67M -$15M -18.3% Dec 31, 2017 10-K 2019-03-01
Q4 2016 $82M +$8.3M +11.3% Dec 31, 2016 10-K 2018-02-28
Q4 2015 $73.7M +$14.1M +23.7% Dec 31, 2015 10-K 2017-03-08
Q4 2014 $59.6M +$5.34M +9.86% Dec 31, 2014 10-K 2016-02-29
Q4 2013 $54.2M +$22.5M +71.1% Dec 31, 2013 10-K 2015-03-02
Q4 2012 $31.7M +$2.37M +8.08% Dec 31, 2012 10-K 2014-03-11
Q4 2011 $29.3M Dec 31, 2011 10-K 2013-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.